Data investigation

GLP-1 Units to mg Dosage Chart: Semaglutide & Tirzepatide

Compounded semaglutide and tirzepatide are dosed in mg but drawn in insulin-syringe units. The complete unit-to-mg chart for common compounded concentrations, the formula behind it, and worked answers like how many units is 2.5 mg of tirzepatide.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
11 min read·7 citations

This dosing chart is part of Weight Loss Rankings' living editorial database — 1,160+ research articles and 630+ editorially reviewed GLP-1 telehealth providers, sourced only from primary FDA labels and peer-reviewed PubMed literature.

Compounded semaglutide and tirzepatide are prescribed in milligrams but drawn into the syringe in units — and getting that conversion wrong is one of the most common compounded GLP-1 dosing errors. The reason is that the vial is liquid, the syringe is a U-100 insulin syringe, and the relationship between "units on the syringe" and "milligrams of drug delivered" depends entirely on the concentration printed on the vial label. This article is the complete static reference: the formula, the lookup tables for every common compounded concentration of semaglutide and tirzepatide, and the worked math behind the most-searched dosing questions on Google. If you want an interactive version, the same math powers our GLP-1 unit converter.

The formula (the only one you need)

Every standard insulin syringe sold in the US is labeled U-100, which means 100 units = 1 mL. One unit is therefore exactly 0.01 mL of liquid — FDA's own dosing-error alert describes a U-100 syringe as 1 mL and a 5-unit dose as 0.05 mL[5]. This holds for every brand of U-100 syringe.

A compounded GLP-1 vial is a known concentration of active drug dissolved in sterile water — for example, 5 mg/mL tirzepatide or 10 mg/mL semaglutide. The concentration is printed on the vial label by the compounding pharmacy. To translate between "mg of drug" and "units on the syringe," use:

units = (mg × 100) ÷ concentration (mg/mL)

mg = (units × concentration (mg/mL)) ÷ 100

That is the entire math. Everything else in this article is the result of applying those two equations to every common dose at every common concentration.

Common compounded concentrations (2026)

Compounding pharmacies do not all use the same concentration. The most common ones we have observed across the GLP-1 injection providers we review as of 2026 are:

  • Semaglutide: 2 mg/mL, 5 mg/mL, 10 mg/mL, and 25 mg/mL. The 2 mg/mL and 5 mg/mL strengths are by far the most common; the 10 mg/mL and 25 mg/mL strengths show up in higher-titration kits and stack vials.
  • Tirzepatide: 5 mg/mL, 10 mg/mL, 20 mg/mL, 30 mg/mL, and 40 mg/mL. The 5 mg/mL and 10 mg/mL strengths are the most common starting kits; 20-40 mg/mL appear in maintenance and high-dose vials so the patient can draw fewer units per injection.

These are the columns in the reference tables below. If your vial is a concentration that is not listed, plug the number into the formula above (or use the interactive calculator) to get an exact answer.

Semaglutide: complete units-by-dose reference table

The rows below are the branded semaglutide dose steps (0.25, 0.5, 1, 1.7 and 2.4 mg for Wegovy[1]; 0.25, 0.5, 1 and 2 mg for Ozempic[2]) plus 1.5 mg, a common compounded intermediate step that is not on either label. Wegovy's label now also allows adults on 2.4 mg for at least 4 weeks to step up to a maximum of 7.2 mg weekly for weight reduction, delivered as a single 0.75 mL Wegovy HD pen[1]; we leave it off the table because at common compounded strengths it would be 144 units at 5 mg/mL or 360 units at 2 mg/mL, more than one 1 mL syringe holds. Here are the unit measurements at every common compounded concentration. Read across the row for your dose, find your vial concentration column, and that is the unit mark to draw to on the U-100 insulin syringe.

Dose (mg)2 mg/mL5 mg/mL10 mg/mL25 mg/mL
0.25 mg12.5 units5 units2.5 units1 units
0.5 mg25 units10 units5 units2 units
1 mg50 units20 units10 units4 units
1.5 mg75 units30 units15 units6 units
1.7 mg85 units34 units17 units6.8 units
2 mg100 units40 units20 units8 units
2.4 mg120 units48 units24 units9.6 units

A few of these values do not land on a clean syringe gradation — for example, 1.7 mg at 25 mg/mL works out to 6.8 units, which a U-100 syringe with 1-unit gradations cannot draw precisely. In practice, your pharmacy should ship you a concentration that produces clean unit values for your prescribed dose. If your math gives you a fractional unit smaller than your syringe gradation, call the pharmacy before injecting. Any value above 100 units (for example, 2.4 mg at 2 mg/mL = 120 units) is more than a full 1 mL syringe, and any value above 50 units will not fit in a 0.5 mL syringe; if your dose lands there, the concentration or syringe is wrong for that dose and you should ask the pharmacy rather than splitting the draw on your own.

Magnitude comparison

Wegovy semaglutide standard titration ladder — milligram per weekly dose at each step. The 2.4 mg recommended maintenance dose is roughly 10x the 0.25 mg starter dose (the label also allows an optional step to a 7.2 mg maximum for adult weight reduction). Unit-on-syringe equivalents at a 5 mg/mL compounded concentration shown in notes. Source: Wegovy Prescribing Information (DailyMed).[1]

  • Week 1-4 starter (0.25 mg)0.25 mg
    = 5 units on a 5 mg/mL vial
  • Week 5-8 titration (0.5 mg)0.50 mg
    = 10 units on a 5 mg/mL vial
  • Week 9-12 titration (1.0 mg)1.00 mg
    = 20 units on a 5 mg/mL vial
  • Week 13-16 titration (1.7 mg)1.70 mg
    = 34 units on a 5 mg/mL vial
  • Week 17+ recommended maintenance (2.4 mg)2.40 mg
    = 48 units on a 5 mg/mL vial
Wegovy semaglutide standard titration ladder — milligram per weekly dose at each step. The 2.4 mg recommended maintenance dose is roughly 10x the 0.25 mg starter dose (the label also allows an optional step to a 7.2 mg maximum for adult weight reduction). Unit-on-syringe equivalents at a 5 mg/mL compounded concentration shown in notes. Source: Wegovy Prescribing Information (DailyMed).

Tirzepatide: complete units-by-dose reference table

Same format for tirzepatide, covering the labeled dose steps: a 2.5 mg starter for 4 weeks, then 2.5 mg increases at least 4 weeks apart up to the 15 mg maximum for both Zepbound and Mounjaro in adults[3][4].

Dose (mg)5 mg/mL10 mg/mL20 mg/mL30 mg/mL40 mg/mL
2.5 mg50 units25 units12.5 units8.33 units6.25 units
5 mg100 units50 units25 units16.67 units12.5 units
7.5 mg150 units75 units37.5 units25 units18.75 units
10 mg200 units100 units50 units33.33 units25 units
12.5 mg250 units125 units62.5 units41.67 units31.25 units
15 mg300 units150 units75 units50 units37.5 units

Notice how dramatically the unit value drops as concentration rises. A 5 mg dose draws 100 units on a 5 mg/mL vial but only 12.5 units on a 40 mg/mL vial. Same drug, same milligrams, eight-fold difference in syringe volume. This is exactly why you cannot share unit instructions between patients on different concentrations. Note too that every entry above 100 units (7.5 mg and up at 5 mg/mL, 12.5 mg and up at 10 mg/mL) exceeds a full 1 mL syringe.

Worked example: How many units is 2.5 mg of tirzepatide?

This is the most-searched compounded GLP-1 dosing question on Google. The answer depends entirely on your vial concentration. Plugging 2.5 mg into the formula units = (mg × 100) / concentration:

  • 5 mg/mL tirzepatide: (2.5 × 100) / 5 = 50 units
  • 10 mg/mL tirzepatide: (2.5 × 100) / 10 = 25 units
  • 20 mg/mL tirzepatide: (2.5 × 100) / 20 = 12.5 units
  • 30 mg/mL tirzepatide: (2.5 × 100) / 30 ≈ 8.33 units (falls between marks; not precisely drawable on a standard syringe)
  • 40 mg/mL tirzepatide: (2.5 × 100) / 40 = 6.25 units (also between marks)

The 5 mg/mL and 10 mg/mL answers (50 and 25 units) are the ones most patients land on, because those are the two most common starter-kit concentrations. At 30 and 40 mg/mL the 2.5 mg starter dose does not land on a syringe mark at all, which is one reason high-strength vials are a poor fit for the lowest doses.

Worked example: How many mg is 40 units of semaglutide?

Inverse formula: mg = (units × concentration) / 100. Plugging in 40 units of semaglutide:

  • 2 mg/mL semaglutide: (40 × 2) / 100 = 0.8 mg
  • 5 mg/mL semaglutide: (40 × 5) / 100 = 2.0 mg
  • 10 mg/mL semaglutide: (40 × 10) / 100 = 4.0 mg
  • 25 mg/mL semaglutide: (40 × 25) / 100 = 10.0 mg

This is the safety lesson in one example: 40 units delivers 0.8 mg on the lowest common concentration but 12.5x more drug on the highest. The recommended Wegovy maintenance dose is 2.4 mg and the label maximum is 7.2 mg[1], so a patient who accidentally drew 40 units from a 25 mg/mL vial would receive 10 mg — about four times the usual maintenance dose and more than any labeled Wegovy dose. This is why concentration is the load-bearing field on a compounded vial label.

Worked example: How many mg is 50 units of semaglutide?

  • 2 mg/mL semaglutide: (50 × 2) / 100 = 1.0 mg
  • 5 mg/mL semaglutide: (50 × 5) / 100 = 2.5 mg
  • 10 mg/mL semaglutide: (50 × 10) / 100 = 5.0 mg
  • 25 mg/mL semaglutide: (50 × 25) / 100 = 12.5 mg

Note that 5.0 mg and 12.5 mg of semaglutide both exceed the 2.4 mg recommended Wegovy maintenance dose[1] and the 2 mg Ozempic maximum dose[2], and 12.5 mg is also well above the 7.2 mg Wegovy maximum[1]. If you are drawing 50 units and your vial is 10 mg/mL or 25 mg/mL, stop and verify with your prescriber before injecting.

Worked example: How many mg is 20 units of tirzepatide?

  • 5 mg/mL tirzepatide: (20 × 5) / 100 = 1.0 mg
  • 10 mg/mL tirzepatide: (20 × 10) / 100 = 2.0 mg
  • 20 mg/mL tirzepatide: (20 × 20) / 100 = 4.0 mg
  • 30 mg/mL tirzepatide: (20 × 30) / 100 = 6.0 mg
  • 40 mg/mL tirzepatide: (20 × 40) / 100 = 8.0 mg

20 units is a common "round number" instruction from telehealth clinicians, and the resulting milligram dose spans 1.0 mg (a sub-starter dose) to 8.0 mg (between the 7.5 mg and 10 mg titration steps of Zepbound[3]). Same syringe mark, five different milligram outcomes across the five concentrations.

Why concentration matters (the only safety point)

The single most important takeaway from this entire reference page is: the same number of units delivers a different milligram dose at every concentration. A unit is a volume measurement on the syringe, not a dose of drug. The drug content of that volume is set by the vial concentration, which is set by the compounding pharmacy.

Telehealth platforms often instruct patients in units rather than milligrams ("draw to the 25 mark") because units are what the patient actually has to do. That works only as long as the concentration in the vial does not change. The most common dosing-error scenarios we see are:

  • The pharmacy switched concentrations between refills and the patient kept drawing the old unit count.
  • A patient on tirzepatide assumed semaglutide unit instructions translate (they do not — the concentrations are different).
  • A patient stacked vials from two pharmacies with different concentrations and used the unit count from the wrong vial.
  • A friend or partner started on the same drug at a different concentration and the patient used their unit count.

Every one of those errors is preventable by re-reading the vial label and re-running the unit conversion every time you open a new vial.

What FDA has documented about unit-conversion errors

This is not a hypothetical risk. In a July 2024 alert, FDA reported adverse events, some requiring hospitalization, linked to dosing errors with compounded semaglutide in multiple-dose vials[5]. Most reports involved patients drawing more than the prescribed dose, receiving five to 20 times the intended amount; in several, patients told to draw 5 units (0.05 mL) with a U-100 syringe drew 50 units instead. FDA also described clinicians miscalculating the mg-to-units conversion, causing 5- to 10-fold overdoses — in one case a prescriber intended 0.25 mg (5 units) but wrote 25 units[5]. That example matches the 5 mg/mL column of the table above, and it is exactly the arithmetic this page exists to check. FDA's current guidance on unapproved GLP-1s extends the dosing concern to compounded tirzepatide as well, including adverse events tied to doses or titration faster than the approved labels allow, and asks patients to talk with their prescriber or compounder about how to measure the intended dose[6].

Compounded semaglutide and tirzepatide are not FDA-approved, and their legal footing changed after the shortages ended. FDA declared the tirzepatide injection shortage resolved on December 19, 2024, and the semaglutide injection shortage resolved on February 21, 2025; the transition periods for pharmacies and outsourcing facilities to stop making essentially-copy versions have since ended, and FDA states that neither drug is on its shortage list or the 503B bulks list[7]. State-licensed pharmacies can still compound in limited circumstances, so compounded vials remain in circulation — which is why the conversion math on this page still matters, and why the concentration printed on your own vial label always governs.

How to find your concentration

The concentration should be printed on the vial label by the compounding pharmacy. Look for a value formatted like 5 mg/mL, 10 mg/mL, or 2.5 mg/mL. It is usually printed near the drug name and the lot number. If the label only lists the total mg in the vial and the total mL, divide the two:

concentration (mg/mL) = total mg in vial ÷ total mL in vial

For example, a vial labeled "25 mg total / 5 mL" is a 5 mg/mL vial. A vial labeled "10 mg total / 2 mL" is a 5 mg/mL vial. A vial labeled "20 mg total / 2 mL" is a 10 mg/mL vial.

If the concentration is not on the label and you cannot derive it from total mg and total mL, call the pharmacy before injecting. Do not guess. Do not assume it is the same as your last vial. Do not assume it is the same as a friend's vial. The compounding pharmacy keeps the concentration on file for every batch they ship.

Use the interactive calculator instead

Static tables answer the most common cases, but if your dose or concentration is off the chart, our interactive tool runs the same formula in real time and shows you the exact unit mark to draw to (rounded to the nearest 0.5 unit, since that is what an insulin syringe can actually deliver):

  • GLP-1 Unit Converter — interactive mg ↔ units calculator with rounding to the nearest syringe gradation. Same engine as the tables on this page; built for the cases the tables do not cover.

Frequently Asked Questions

On a U-100 insulin syringe, 100 units equals exactly 1 mL of liquid. Each unit is therefore 0.01 mL. The unit is a volume marking, not a dose of drug. The actual milligrams of GLP-1 you draw depends on the concentration of your vial.
Yes, as long as the syringe is labeled U-100, the standard insulin syringe in the US. On any U-100 syringe, whatever the brand, 100 units equals 1 mL and 1 unit equals 0.01 mL. U-40 and U-500 syringes also exist (for veterinary insulin and for concentrated U-500 human insulin), and on those the unit marks correspond to different volumes, so a unit count calculated for U-100 is wrong on them. Check that the barrel or packaging says U-100 before you use the tables on this page.
A tuberculin syringe is graduated in mL rather than units. 0.1 mL on a tuberculin syringe equals 10 units on a U-100 insulin syringe (since 1 unit = 0.01 mL). The math is identical — you just convert your prescribed unit count to mL by dividing by 100. Only switch syringe types if your prescriber or pharmacist tells you to, and ask them to confirm the mL volume for your dose, because reading a mL scale against a unit instruction is exactly the kind of conversion FDA has linked to dosing errors.
It depends on the syringe size and brand: smaller-barrel syringes (0.3 mL and 0.5 mL) have finer markings than 1 mL syringes, and some 0.3 mL syringes add half-unit marks. Check the scale printed on your own barrel. You cannot reliably draw a fraction smaller than the marked increment, which is why your prescriber or pharmacy should choose a concentration and syringe that put your dose on a clean mark. FDA has specifically urged prescribers and compounders to give patients a syringe sized for the intended dose.
Different compounding pharmacies use different concentrations, and the same pharmacy can change concentrations between refills. Always re-read the vial label on every new vial and recalculate your unit dose using the formula above (or the interactive unit converter). Drawing the same number of units from a vial at a different concentration will deliver a different milligram dose. If the concentration changed unexpectedly, call your prescriber and the pharmacy before injecting.

Related research and tools

Further reading

References

  1. 1.Novo Nordisk; U.S. National Library of Medicine. WEGOVY (semaglutide) injection; WEGOVY (semaglutide) tablets — US Prescribing Information (DailyMed SetID ee06186f-2aa3-4990-a760-757579d8f77b). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. 2.Novo Nordisk; U.S. National Library of Medicine. OZEMPIC (semaglutide) injection — US Prescribing Information (DailyMed SetID adec4fd2-6858-4c99-91d4-531f5f2a2d79). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  3. 3.Eli Lilly and Company; U.S. National Library of Medicine. ZEPBOUND (tirzepatide) injection — US Prescribing Information (DailyMed SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  4. 4.Eli Lilly and Company; U.S. National Library of Medicine. MOUNJARO (tirzepatide) injection — US Prescribing Information (DailyMed SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  5. 5.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
  6. 6.U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  7. 7.U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA Drug Alerts and Statements. 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Where to get tirzepatide (Mounjaro / Zepbound) safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

8.1

Oak

Compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up

Read full review →

From $250/mo (starting dose)

Get started →
7.8

SnagRx

Compounded semaglutide and tirzepatide at a flat lifetime price

Read full review →

From $149/mo

Get started →
7.1

AgelessRx

Longevity-focused GLP-1 care with microdosing and brand-name options

Read full review →

From $209/mo (2-month plan rate)

Get started →